On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...